Charles Hugh-Jones

Direttore Tecnico/Scientifico/R&S presso FRESENIUS MEDICAL CARE AG

56 anni

Health Technology

Health Services

Profilo

Charles Hugh-Jones is the Global Chief Medical Officer at Fresenius Medical Care AG, starting in 2026.
Formerly, Dr. Hugh-Jones was Chief Executive Officer at Volastra Therapeutics, Inc., Chief Medical Officer at Allergan UC from 2018 to 2020, and worked at Addleshaw Booth & Co. from 2004 to 2007.

Posizioni attive di Charles Hugh-Jones

Società	Posizione	Inizio
FRESENIUS MEDICAL CARE AG	Direttore Tecnico/Scientifico/R&S	01/01/2026

Tutte le posizioni attive di Charles Hugh-Jones

Precedenti posizioni note di Charles Hugh-Jones

Società	Posizione	Fine
Volastra Therapeutics, Inc. Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics	Amministratore Delegato	27/05/2025
ALLERGAN PLC	Direttore Tecnico/Scientifico/R&S	08/05/2020

Vedi nel dettaglio l'esperienza di Charles Hugh-Jones

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Charles Hugh-Jones

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
Fresenius Medical Care AG Fresenius Medical Care AG Medical/Nursing ServicesHealth Services Manufactures and supplies renal and dialysis products	Health Services
Allergan Ltd. (Ireland) Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products	Health Technology
Volastra Therapeutics, Inc. Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics	Health Technology